Evidence map›Paper›PMID 39318787›Full record

ArticleEClinicalMedicine2024

Comparing approaches for chemoprevention for school-based malaria control in Malawi: an open label, randomized, controlled clinical trial.

Alick Sixpence, Maclean Vokhiwa, Wangisani Kumalakwaanthu, Nicola J Pitchford, Karl B Seydel, Laurence S Magder, Miriam K Laufer, Don P Mathanga, Lauren M Cohee

Registry-linked trialAbstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05244954 (Clinical Trial to Evaluate Intermittent Screening and Treatment and Intermittent Preventive Treatment of Malaria in Asymptomatic Schoolchildren to Decrease P. Falciparum Infection and Transmission), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05244954 phase4completednot on this map

Clinical Trial to Evaluate Intermittent Screening and Treatment and Intermittent Preventive Treatment of Malaria in Asymptomatic Schoolchildren to Decrease P. Falciparum Infection and Transmission

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2022 to 2022Enrolled746ConditionsMalaria,Falciparum, Anemia in ChildrenArmsDihydroartemisinin-Piperaquine, Chloroquine
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alick SixpenceDepartment of Epidemiology and Department of Global Health, Boston University School of Public Health, 715 Albany St, Talbot Building, Boston, MA, 02118, USA.
Maclean VokhiwaTraining & Research Unit of Excellence (TRUE), 1 Kufa Road, Mandala, P.O Box 30538, Chichiri, Blantyre 3, Malawi.
Wangisani KumalakwaanthuMalaria Alert Centre (MAC), Kamuzu University of Health Sciences (KUHeS), Private Bag 360, Chichiri, Blantyre 3, Malawi.
Nicola J PitchfordSchool of Psychology, University of Nottingham, Nottingham, UK.
Karl B SeydelDepartment of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, 48824, USA.
Laurence S MagderDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Miriam K LauferCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Don P MathangaMalaria Alert Centre (MAC), Kamuzu University of Health Sciences (KUHeS), Private Bag 360, Chichiri, Blantyre 3, Malawi.
Lauren M CoheeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.

Funding

Mentoring in patient-oriented research in global healthK24AI114996 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LAUFER, MIRIAM K. · 2016 to 2025
$1.6M
Impact of P. falciparum diversity on transmission reducing immunityK23AI135076 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI COHEE, LAUREN M · 2018 to 2022
$940k
NIAID NIH HHS K23 AI135076NIAID NIH HHS K24 AI114996
6 · The paper itself

Abstract

Background: School-age children in sub-Saharan Africa suffer an underappreciated burden of malaria which threatens their health and education. To address this problem, we compared the efficacy of two school-based chemoprevention approaches: giving all students intermittent preventive treatment (IPT) or screening and treating only students with detected infections (IST). Methods: In a three-arm, open-label, randomized, controlled trial (NCT05244954) in Malawi, 746 primary school students, aged 5-19 years, were individually randomized within each grade-level to IPT (n = 249), IST with a high-sensitivity rapid diagnostic test (hs-RDT, n = 248), or control (n = 249). At six-week intervals three times within the peak malaria transmission season (February-June 2022) treatment with dihydroartemisinin-piperaquine (DP) was administered to girls <10 years and all boys, and chloroquine to older girls. The primary outcome was Findings: Outcomes analyses included 727 (97%) participants. At the end of the study, prevalence of Interpretation: Results support implementation of IST with hs-RDTs or IPT for reduction in the prevalence of infection. Based on reductions in clinical malaria, IPT may provide additional benefits warranting further consideration by school-based malaria chemoprevention programs. Funding: Doris Duke Charitable Foundation Clinical Scientist Development Award 2021191, U.S. NIH K24AI114996 & K23AI135076.

Indexed as

AnaemiaChemopreventionCognitionEducationMalariaSchool health

Identifiers

PMID39318787
PMCPMC11421355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.